An observational study in Polyvascular Disease, sponsored by Harbin Medical University. Recruiting at 1 site in China. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-12-27.
Sponsored by Harbin Medical University · Observational
Harbin Medical University is the lead sponsor of 87 studies on the registry; 32 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Patients with polyvascular disease in the 2nd Affiliated Hospital of Harbin Medical University
Task 1:
Task 2:
Exclusion Criteria:
Task 1:
Task 2:
Diagnostic Test: Magnetic Resonance Angiography, Ocular OCTA, CT Angiography
Magnetic Resonance Angiography of intracranial artery, carotid artery, renal artery and lower extremity artery, CT angiography of coronary artery or intracranial artery
Task1: MACE
All cause death, stroke, myocardial reinfarction, unplanned revascularization, lower extremity artery disease
Time frame: 1 year
Task2: Plaque characteristics
Plaque morphology on OCT
Time frame: 1 year
Plan to share: No
No publications or documents are linked to this record.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Harbin Medical University